Atlas Trials

An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Pitt Hopkins Syndrome

Clinical trial NCT07150026 · RECRUITING

Trial details

NCT number
NCT07150026
Sponsor
Unravel Biosciences, Inc.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Pitt Hopkins Syndrome
Start date
2026-03-15
Primary completion
2026-12-31
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.